Medicare Part D coverage · 24 · RxCUI 1855072
24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee]
Per the CMS 2026 Part D formulary file, 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] is covered by 1,479 Medicare Part D plans (29.3% of enrollable products), averaging Tier 4.1, with prior authorization required on 1.1% of covering formularies.
- 29.3%
- Plan coverage
- 1,479
- Plans covering
- T4.1
- Avg tier
- 1.1%
- Prior auth required
What the CMS Formulary Data Shows for 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee]
Per the CMS 2026 Part D formulary file, 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] (RxNorm concept RXCUI 1855072, generic name 24) appears on 95 distinct formulary files spanning 1,479 Medicare Part D plan offerings - 29.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.1.
Real-world access to 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] depends on utilization management as much as tier placement: 1.1% of covering formularies require prior authorization. 0% require step therapy. 65.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 4,889 Part D beneficiaries filled 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] in 2023, with total plan-and-beneficiary spending of $41,491,958 and an average per-beneficiary annual cost of $8,486.80. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] today.
Coverage Details
- Formularies covering
- 95
- Plans covering
- 1,479
- Coverage rate
- 29.3%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 1.1% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 65.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 4,889
- Total spending
- $41,491,958
- Avg per beneficiary
- $8,486.80
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee]
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T5 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T5 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T5 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T5 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T5 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee]
95 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | No | $0 | CO |
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | No | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | No | $0 | MD |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | No | $0 | NY |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $0 | MO |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | No | $0 | AR |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | No | $4.80 | FL |
| Provider Partners Texas Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Texas, Inc. | T1 | No | $4.80 | TX |
Show the next 30 plans
| Texas Independence Health Plan, Inc. (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | No | $4.80 | TX |
| Texas Independence Community Plan (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | No | $4.80 | TX |
| Tribute Select (HMO-POS I-SNP) | Arkansas Superior Select, Inc. | T1 | No | $8.90 | AR |
| ATRIO Special Needs Plan (HMO D-SNP) | Atrio Health Plans | T1 | No | $10.50 | OR |
| ATRIO Special Needs Plan (HMO D-SNP) | Atrio Health Plans | T1 | No | $10.50 | OR |
| Provider Partners Illinois Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Illinois | T1 | No | $15.20 | IL |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Arizona | T1 | No | $17.00 | AZ |
| Alterwood Advantage Dual Value (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | No | $31.20 | MD |
| Valor Health Plan (HMO I-SNP) | TSG Guard, Inc. | T1 | No | $31.40 | OH |
| Provider Partners Pennsylvania Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $32.70 | PA |
| Provider Partners Pennsylvania Essential Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $32.70 | PA |
| WV Senior Advantage (HMO I-SNP) | West Virginia Senior Advantage, Inc. | T1 | No | $32.70 | WV |
| Abilis Health (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $35.90 | KY, TN |
| Provider Partners North Carolina Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $36.20 | NC |
| Provider Partners North Carolina Essential Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $36.20 | NC |
| CommuniCare Advantage ISNP (HMO I-SNP) | OH CHS SNP Inc. | T1 | No | $38.40 | IN, MD, OH |
| Provider Partners Indiana Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $38.40 | IN |
| Provider Partners Indiana Essential Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $38.40 | IN |
| Provider Partners Kentucky Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Kentucky | T1 | No | $38.40 | KY |
| Provider Partners Missouri Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $43.00 | MO |
| Provider Partners Missouri Essential Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $43.00 | MO |
| Nascentia Skilled Nursing Facility (HMO I-SNP) | Visiting Nurse Association OF Central NEW York | T1 | No | $58.80 | NY |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Prominence Plus (HMO) | Prominence Healthfirst | T3 | No | $0 | NV |
| Prominence Plus (HMO) | Prominence Healthfirst | T3 | No | $0 | NV |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst | T3 | No | $0 | NV |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst | T3 | No | $0 | NV |
| Prominence Giveback (HMO) | Prominence Healthfirst | T3 | No | $0 | NV |
| Prominence Plus (HMO) | Prominence Healthfirst OF Florida Inc | T3 | No | $0 | FL |
| Prominence Giveback (HMO) | Prominence Healthfirst OF Florida Inc | T3 | No | $0 | FL |
Showing top 50 of 95 plans.
Frequently Asked Questions
Is 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] covered by Medicare Part D?
Yes, 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] is covered by 1,479 Medicare Part D plans (29.3% of all Part D formularies).
What tier is 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] on Medicare Part D plans?
24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] averages Tier 4.1 across Part D plans, ranging from Tier 1 to Tier 5.
Does 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] require prior authorization?
1.1% of Part D formularies require prior authorization for 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee]. Step therapy: 0%. Quantity limits: 65.3%.
How much does Medicare spend on 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee]?
In 2023, total Medicare Part D spending on 24 HR calcifediol 0.03 MG Extended Release Oral Capsule [Rayaldee] was $41,491,958, covering 4,889 beneficiaries. The average spend per beneficiary was $8,486.80.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- brivaracetam 10 MG Oral Tablet [Briviact] T4.1
- rifaximin 550 MG Oral Tablet [XIFAXAN] T4.1
- tenofovir disoproxil fumarate 200 MG Oral Tablet [Viread] T4.1
- pomalidomide 1 MG Oral Capsule T4.1
- 1 ML benralizumab 30 MG/ML Prefilled Syringe [Fasenra] T4.1
- deferasirox 250 MG Tablet for Oral Suspension T4.1
Similar prior-authorization rate
- morphine sulfate 4 MG/ML Oral Solution 1.1% PA
- insulin degludec 100 UNT/ML Injectable Solution [Tresiba] 1.1% PA
- 3 ML insulin degludec 100 UNT/ML Pen Injector [Tresiba] 1.1% PA
- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection 1.1% PA
- oxycodone hydrochloride 30 MG Oral Tablet 1.2% PA
- ribavirin 200 MG Oral Tablet 1.2% PA